C-C Chemokine Receptor Type 4 - Pipeline Review, H2 2019
According to the recently published report 'C-C Chemokine Receptor Type 4 - Pipeline Review, H2 2019'; C-C Chemokine Receptor Type 4 (K5-5 or CD194 or CCR4) pipeline Target constitutes close to 7 molecules. Out of which approximately 6 molecules are developed by companies and remaining by the universities/institutes.
C-C Chemokine Receptor Type 4 (K5-5 or CD194 or CCR4) - C-C chemokine receptor type 4 is a protein encoded by the CCR4 gene. CCR4 is expressed on Th2 T lymphocytes and is up-regulated by T cell receptor activation. This receptor also plays an important role in trafficking of dendritic cells. The CC chemokines CCL3, CCL5, CCL17 and CCL22 signal through this receptor.
The report 'C-C Chemokine Receptor Type 4 - Pipeline Review, H2 2019' outlays comprehensive information on the C-C Chemokine Receptor Type 4 (K5-5 or CD194 or CCR4) targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type; that are being developed by Companies / Universities.
It also reviews key players involved in C-C Chemokine Receptor Type 4 (K5-5 or CD194 or CCR4) targeted therapeutics development with respective active and dormant or discontinued projects. Currently, The molecules developed by companies in Pre-Registration, Phase II, Phase I and Preclinical stages are 1, 1, 1 and 3 respectively. Similarly, the universities portfolio in Phase I stages comprises 1 molecules, respectively. Report covers products from therapy areas Oncology, Central Nervous System, Dermatology, Ear Nose Throat Disorders, Gastrointestinal, Immunology, Ophthalmology and Respiratory which include indications Gastric Cancer, Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma), Non-Hodgkin Lymphoma, Non-Small Cell Lung Cancer, Renal Cell Carcinoma, T-Cell Lymphomas, Triple-Negative Breast Cancer (TNBC), Adenocarcinoma Of The Gastroesophageal Junction, Allergic Asthma, Allergic Conjunctivitis, Atopic Dermatitis (Atopic Eczema), Autoimmune Disorders, Cervical Cancer, Chronic Urticaria Or Hives, Colon Tumor, Colorectal Cancer, Eosinophilic Esophagitis, Esophageal Cancer, Head And Neck Cancer Squamous Cell Carcinoma, Hematological Tumor, Metastatic Hepatocellular Carcinoma (HCC), Mycosis Fungoides, Nasopharyngeal Cancer, Oral Cancer, Ovarian Cancer, Pancreatic Tumor, Rhinosinusitis, Sezary Syndrome, Solid Tumor, Spinal Cord Disorders, T-Cell Leukemia, Transitional Cell Carcinoma (Urothelial Cell Carcinoma) and Tropical Spastic Paraparesis.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.Download eBook